Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | CCT301-38 |
| Trade Name | |
| Synonyms | CCT301 38|CCT30138 CAR-T cells|autologous anti-AXL CAR-T Cells CCT30138 |
| Drug Descriptions |
CCT301-38 consists of autologous T cells engineered to express an AXL-targeting chimeric antigen receptor (CAR), which are activated in the tumor microenvironment, potentially resulting in the killing of tumor cells expressing AXL (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C154276 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| CCT301-38 | CCT301-38 | 0 | 0 |